Open access
Open access
Powered by Google Translator Translator

Ophthalmology

Cataract surgery: both eyes on the same day or on different days?

24 Jun, 2022 | 10:55h | UTC

Cataract surgery: both eyes on the same day or on different days? – Evidently Cochrane

Original Study: Immediate sequential bilateral surgery versus delayed sequential bilateral surgery for cataracts – Cochrane Library

 

Systematic Review: Rituximab for thyroid‐associated ophthalmopathy.

20 Jun, 2022 | 01:16h | UTC

Rituximab for thyroid‐associated ophthalmopathy – Cochrane Library

Summary: What are the benefits and risks of rituximab (a medicine that reduces inflammation) for the treatment of thyroid-associated ophthalmopathy (a disease affecting the tissues surrounding the eyes) – Cochrane Library

 

Does this patient with acute infectious conjunctivitis have a bacterial infection? The rational clinical examination systematic review.

17 Jun, 2022 | 11:12h | UTC

Does This Patient With Acute Infectious Conjunctivitis Have a Bacterial Infection? The Rational Clinical Examination Systematic Review – JAMA (free for a limited period)

 

Commentary on Twitter

 

Systematic Review: Rho kinase inhibitor for primary open‐angle glaucoma and ocular hypertension.

15 Jun, 2022 | 10:30h | UTC

Rho kinase inhibitor for primary open‐angle glaucoma and ocular hypertension – Cochrane Library

Summary: Rho kinase inhibitors for primary open-angle glaucoma and ocular hypertension – Cochrane Library

 

Systematic Review: Impact of vision impairment and ocular morbidity and their treatment on depression and anxiety in children.

14 Jun, 2022 | 10:34h | UTC

Impact of vision impairment and ocular morbidity and their treatment on depression and anxiety in children: A systematic review – Ophthalmology

Commentary: Vision Impairment Associated with Greater Depression, Anxiety in Children – HCP Live

 

RCT: Marine Omega-3 Fatty acid supplementation does not reduce the incidence of dry eye disease in healthy adults.

10 Jun, 2022 | 12:25h | UTC

Efficacy of Marine ω-3 Fatty Acid Supplementation vs Placebo in Reducing Incidence of Dry Eye Disease in Healthy US Adults: A Randomized Clinical Trial – JAMA Ophthalmology (free for a limited period)

Invited Commentary: Another Disappointment for ω-3 Fatty Acid and Dry Eye Disease – JAMA Ophthalmology (free for a limited period)

 

Commentary on Twitter

 

Systematic Review: Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure.

8 Jun, 2022 | 10:57h | UTC

Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure – Cochrane Library

Summary: Steroids plus antibiotics versus antibiotics alone for the treatment of acute endophthalmitis after eye surgery or injections into the eye – Cochrane Library

 

Association between retinal layer thickness and cognitive decline in older adults.

1 Jun, 2022 | 11:13h | UTC

Association Between Retinal Layer Thickness and Cognitive Decline in Older Adults – JAMA Ophthalmology

Commentaries:

Retinal Layer Thickness Linked to Risk of Cognitive Decline – NeurologyToday

Retinal Layer Thickness Linked to Cognitive Decline in Older Adults – HealthDay

 

Commentary on Twitter

 

Systematic Review: Antibiotic prophylaxis for corneal abrasion.

1 Jun, 2022 | 11:06h | UTC

Antibiotic prophylaxis for corneal abrasion – Cochrane Library

Summary: Can ocular antibiotics treatment prevent eye infection following a corneal abrasion? – Cochrane Library

 

WHO launches new guide on integrating eye care in health systems.

30 May, 2022 | 11:48h | UTC

News Release: WHO launches new guide on integrating eye care in health systems – World Health Organization

WHO Guidance: Eye care in health systems: guide for action – World Health Organization

 

Review: Trachoma.

30 May, 2022 | 10:47h | UTC

Trachoma – Nature Reviews Disease Primer (if the link is paywalled, try this one)

Infographic: Trachoma – Nature Reviews Disease Primer (if the link is paywalled, try this one)

 

Commentaries on Twitter

 

Adverse effects and Safety in Glaucoma Patients – Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD) – A Delphi Consensus Statement.

26 May, 2022 | 10:14h | UTC

Adverse effects and Safety in Glaucoma Patients – Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD) – A Delphi Consensus Statement – American Journal of Ophthalmology

 

USPSTF Recommendation Statement: The current evidence is insufficient to make a recommendation about screening for primary open-angle glaucoma in adults.

25 May, 2022 | 11:46h | UTC

Screening for Primary Open-Angle Glaucoma: US Preventive Services Task Force Recommendation Statement – JAMA

Editorials:

Identifying Glaucoma in Primary Care Offices – JAMA Ophthalmology

Screening for Glaucoma – JAMA

Evidence Report: Screening for Glaucoma in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA

Patient Page: Screening for Primary Open-Angle Glaucoma – JAMA

Author Interview: USPSTF Recommendations: Screening for Primary Open-Angle Glaucoma and Screening for Impaired Visual Acuity in Older Adults

 

USPSTF Recommendation Statement: The current evidence is insufficient to make a recommendation about screening for impaired visual acuity in older adults.

25 May, 2022 | 11:44h | UTC

Screening for Impaired Visual Acuity in Older Adults: US Preventive Services Task Force Recommendation Statement – JAMA

Editorials:

Visual Acuity Screening in Older Adults – JAMA Ophthalmology

Screening for Impaired Visual Acuity in Older Adults – JAMA

Vision Impairment Has Implications for Aging and Health Outcomes, Beyond Ophthalmology – JAMA Network Open

Evidence Report: Screening for Impaired Visual Acuity in Older Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA

Patient Page: Screening for Impaired Visual Acuity in Older Adults – JAMA

Author Interview: USPSTF Recommendations: Screening for Primary Open-Angle Glaucoma and Screening for Impaired Visual Acuity in Older Adults – JAMA

 

M-A: The global prevalence of amblyopia in children.

24 May, 2022 | 07:29h | UTC

The Global Prevalence of Amblyopia in Children: A Systematic Review and Meta-Analysis – Frontiers in Pediatrics

 

Network meta-analysis of different intravenous glucocorticoid regimes for the treatment of Graves’ orbitopathy.

20 May, 2022 | 10:34h | UTC

Network Meta-Analysis of Different Intravenous Glucocorticoid Regimes for the Treatment of Graves’ Orbitopathy – Frontiers in Pharmacology

 

Artificial intelligence for screening of multiple retinal and optic nerve diseases.

9 May, 2022 | 01:18h | UTC

Artificial Intelligence for Screening of Multiple Retinal and Optic Nerve Diseases – JAMA Network Open

 

Commentary on Twitter

 

Advancing the Sustainable Development Goals through improving eye health: a scoping review.

5 May, 2022 | 10:01h | UTC

Advancing the Sustainable Development Goals through improving eye health: a scoping review – The Lancet Planetary Health

 

Current Guidelines on management of amaurosis fugax and transient ischemic attacks.

5 May, 2022 | 09:50h | UTC

Current Guidelines on Management of Amaurosis Fugax and Transient Ischemic Attacks – Asia-Pacific Journal of Ophthalmology

 

Systematic Review: Immediate sequential bilateral surgery versus delayed sequential bilateral surgery for cataracts.

26 Apr, 2022 | 07:52h | UTC

Immediate sequential bilateral surgery versus delayed sequential bilateral surgery for cataracts – Cochrane Library

Summary: Surgery on both eyes on the same day or on different days: which works better to treat cataract in both eyes? – Cochrane Library

 

Retinal age gap as a predictive biomarker of future risk of Parkinson’s disease.

21 Apr, 2022 | 09:54h | UTC

Retinal age gap as a predictive biomarker of future risk of Parkinson’s disease – Age and Ageing

Related: Retinal age gap as a predictive biomarker for mortality risk – British Journal of Ophthalmology (link to abstract – $ for full-text)

 

Cohort Study: Changes in the incidence of retinal vascular occlusions after COVID-19 diagnosis.

18 Apr, 2022 | 10:34h | UTC

Changes in the Incidence of Retinal Vascular Occlusions After COVID-19 Diagnosis – JAMA Ophthalmology

Commentaries:

COVID-19 Diagnosis and Incidence of Retinal Thromboembolism – JAMA Ophthalmology

Threatening Eye Condition Rare After COVID Infection – HealthDay

 

Cohort Study: Use of Phosphodiesterase 5 Inhibitors linked to increased risk of ocular adverse events.

8 Apr, 2022 | 11:04h | UTC

Risk of Ocular Adverse Events Associated With Use of Phosphodiesterase 5 Inhibitors in Men in the US – JAMA Ophthalmology (free for a limited period)

News Release: U.S. insurance claims show strong link between ED medications and vision problems – University of British Columbia

Commentaries:

Phase 4 Studies on Phosphodiesterase 5 Inhibitors – JAMA Ophthalmology (free for a limited period)

Expert reaction to study looking at risk of vision impairment and loss, and use of phosphodiesterase type 5 inhibitors – Science Media Centre

Could Viagra, Cialis Raise Men’s Odds for Eye Trouble? – HealthDay

 

Study Commentary | Advanced glaucoma: surgery lowers pressure in the eye more effectively than eye drops.

8 Apr, 2022 | 10:06h | UTC

Advanced glaucoma: surgery lowers pressure in the eye more effectively than eye drops – National Institute for Health Research

Original Study: Pragmatic RCT: Among patients with advanced glaucoma, primary trabeculectomy resulted in similar quality of life and safety outcomes and achieved a lower intraocular pressure compared with primary medication.

 

Retinal photograph-based deep learning predicts biological age, and stratifies morbidity and mortality risk.

7 Apr, 2022 | 08:18h | UTC

Retinal photograph-based deep learning predicts biological age, and stratifies morbidity and mortality risk – Age and Ageing

Related: Study shows that the retinal age gap might be a potential biomarker of aging linked to increased mortality risk.

 

Stay Updated in Your Specialty

No spam, just news.